Ameritas Investment Partners
CATX icon

Ameritas Investment Partners’s Perspective Therapeutics CATX Stock Holding History

Ameritas Investment Partners’s Portfolio CATX Stock Details CATX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$32K Buy
9,372
+3,896
+71% +$14.7K ﹤0.01% 2513
2026
Q1 		$22.8K Hold
5,476
– – ﹤0.01% 2534
2025
Q4 		$15.1K Hold
5,476
– – ﹤0.01% 2768
2025
Q3 		$18.8K Hold
5,476
– – ﹤0.01% 2688
2025
Q2 		$18.8K Hold
5,476
– – ﹤0.01% 2692
2025
Q1 		$11.7K Hold
5,476
– – ﹤0.01% 2774
2024
Q4 		$17.5K Hold
5,476
– – ﹤0.01% 2690
2024
Q3 		$73.1K Buy
5,476
+863
+19% +$11.5K ﹤0.01% 1970
2024
Q2 		$46K Buy
+4,613
New +$66.7K ﹤0.01% 2184

Other funds holding CATX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
TCG Crossover Management
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
CC
Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $624M AUM 250.2% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AAA
Affinity Asset Advisors New York $2.21B AUM 431.26% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
SSC
Spruce Street Capital New York $510M AUM

Ameritas Investment Partners's CATX Position: Q2 2026 in Review

Ameritas Investment Partners increased its Perspective Therapeutics (CATX) stake by 71% in Q2 2026, buying an estimated $14.7K and bringing the position to 9,372 shares worth $32K. The position accounts for ﹤0.01% of the portfolio, ranked #2513.

Ameritas Investment Partners first reported a position in CATX in Q2 2024 and has held it in 9 quarters since. The position peaked at $73.1K in Q3 2024. 131 funds tracked by Wall St. Rank hold CATX as of Q2 2026.

  • Ameritas Investment Partners held 9,372 shares of Perspective Therapeutics worth $32K as of Q2 2026.
  • Ameritas Investment Partners bought 3,896 Perspective Therapeutics shares in Q2 2026, an estimated $14.7K.
  • Perspective Therapeutics made up ﹤0.01% of Ameritas Investment Partners's portfolio in Q2 2026, its #2513 holding.
  • Ameritas Investment Partners first reported a position in Perspective Therapeutics in Q2 2024 and has held it in 9 quarters since.
  • Ameritas Investment Partners's Perspective Therapeutics position peaked at $73.1K in Q3 2024.
  • 131 funds tracked by Wall St. Rank held Perspective Therapeutics as of Q2 2026.

Based on Ameritas Investment Partners's 13F filing for Q2 2026, filed 13 Aug 2026.